- Country: Brazil
- Summary: Retinol+Ergocalciferol Acquisition (Vit A+D2) 50,000+10.000Ui/Ml Fr 10Ml, Pionoglitazone (Chloride) 30 Mg Compressed Table, 500Mg Tablet, Oxybutinin (Hydrochloride) 5 Mg Compressed, Progester ...
- BRT Ref No: 117547967
- Deadline: 29 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90291/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Retinol Acquisition+Ergocalciferol (Vit A+D2) 50,000+10.000UI/ML FR 10ml, Pioglitazone (Hydrochloride) 30 mg compressed table, oxybutinine (hydrochloride) 5 mg compressed progesterone 100mg gelatinous capsule. Solifenacina 5 mg
codefrom UASG: 92301
Notice from: 10/04/2025 from 08:00 to 17:59 hs
Delivery of the proposal: from 10/04/2025 to 08: 00hs
retinol, composition associated with cholecalciferol, concentration 50,000 IU + 10,000 IU/ml, pharmaceutical form oral solution
quantityConcentration 30 mg
Quantity: 132486
mesalazine, concentration 500 mg, pharmaceutical form prolonged release
quantity: 5142
oxybutinine hydrochloride, concentration 5 mg, pharmaceutical form controlled release
quantity: 897674
progesterone, dosage 100mg
quantity: 161956
solifenacin, compositionSalt Succinato, concentration 5 mg
quantity: 115430
terlipressin, acetate composition, concentration 1 mg, pharmaceutical form lipophyl powder for injectable
quantity: 1866
octreotide, acetate salt, concentration 30 mg, pharmaceutical form liophilic powder for injectable, additional characteristic w/ systemApplication
Quantity: 14
TRITRERINE, Acetate salt composition, 0.1 mg/ml concentration, pharmaceutical form injectable solution, added syringe characteristics
Quantity:416 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRetinol+Ergocalciferol Acquisition (Vit A+D2) 50,000+10.000Ui/Ml Fr 10Ml, Pionoglitazone (Chloride) 30 Mg Compressed Table, 500Mg Tablet, Oxybutinin (Hydrochloride) 5 Mg Compressed, Progester ... - Brazil Tender
The SAO PAULO STATE GOVERNMENT, a Government sector organization in Brazil, has announced a new tender for Retinol+Ergocalciferol Acquisition (Vit A+D2) 50,000+10.000Ui/Ml Fr 10Ml, Pionoglitazone (Chloride) 30 Mg Compressed Table, 500Mg Tablet, Oxybutinin (Hydrochloride) 5 Mg Compressed, Progester .... This tender is published on BrazilTenders under BRT Ref No: 117547967 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-29.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
